Concepta to supply 'myLotus' to Walgreens Boots Alliance

Concepta has agreed to supply the ‘myLotus’ product to Walgreens Boots Alliance, for women's fertility and hormone testing, it announced on Tuesday.

The AIM-traded firm described myLotus as a “revolutionary” home based, self-test product, which was launched in November last year with early 'trying to conceive' users providing personal video feedback and testimonials on their menstrual cycle hormone changes and hormone patterns, enabling women to better understand their menstrual cycle and fertility journey.

It said the supply agreement represented the first commercial partnership forming part of its European Union roll-out plans.

MyLotus recently received CE-mark certification, with the agreement allowing the company to extend its UK relationship with Boots retail stores to other Walgreens Boots Alliance partners across EU markets.

The product was available to women who were planning to start a family, or for those who had previously struggled to naturally conceive, enabling couples an alternative prior to considering more costly IVF treatment.

Concepta expected to release further hormone health and wellbeing tests to complement its fertility offering later in the year.

“We are delighted to work with such a respected British high-street brand and retailer and look forward to supplying myLotus to Boots the Chemist to help improve the chances of a natural pregnancy,” said Concepta chairman Matthew Walls.

“We are now preparing our EU market roll-out plans and will update the market in due course.”